The biosimilars reach the US market as the US insulin space has seen seismic changes in the last few years, with a clamour of ...

While the issue has fallen from the headlines after several moves to cap the cost, some patients with diabetes still often ...

A common artificial sweetener may trigger insulin spikes that lead to the build up of fatty plaques in the arteries, ...

Three U.S. Senators say they are "alarmed" Novo Nordisk discontinued U.S. sales of a popular insulin brand and are demanding answers from the pharmaceutical giant they say left patients without an ...

We know that supplements that promise the world are, for the most part, nothing more than expensive fads, but wanted to ask ...

Despite being off-patent for many years, Humalog and other insulin brands continue to make high sales, with Lilly booking around $3 billion from its product last year, $1.8 billion of which was ...

"And whether you're using Eli Lilly, Sanofi and Novo Nordisk products, your insulin costs will be $35 a month, period," he said. The agreement reached with Novo Nordisk covers popular brands like ...

This is down from $82, reports The New York Times. Lilly will also be reducing the price of its most prescribed insulin brands Humalog and Humulin by 70 percent. Humalog will be priced at $66.40 ...

In the kitchen of her South St. Paul home, Abigail Turner prepares the insulin she uses to manage her type 1 diabetes last February. Minnesota announced a final settlement Monday with the last of ...

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus. Lantus cost $292 for a 30-day supply. Drugmaker Viatris launched two ...